Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation - Quiz - MDSpire

Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation

  • By

  • Yuqin Men

  • Chunyan Wang

  • David O. Popoola

  • Zhi Cao

  • Weikun Tian

  • Robert N. Cooney

  • Qinghe Meng

  • Yamin Li

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation

  • by Yuqin Men, Chunyan Wang, David O. Popoola, Zhi Cao, Weikun Tian, Robert N. Cooney, Qinghe Meng, Yamin Li

  • May 29, 2026

Related Content

Postextubation Pneumonia Tops Ventilator Pneumonia

Older age, male sex, underweight status, reduced activities of daily living, and mild consciousness disturbance were associated with postextubation pneumonia in elective surgical patients.

Predicting major organ complications in primary Sjögren’s disease using a machine learning ensemble strategy: a dual-center retrospective clinical study

Insights into epidemiological and clinical burden of bronchiolitis among hospitalized children: a call for preventive interventions